Jeffrey Ware MD, Presenter: Nothing to Disclose

Ronald L. Wolf MD, PhD, Abstract Co-Author: Nothing to Disclose

Harish Poptani PhD, Abstract Co-Author: Nothing to Disclose

Donald M. O'Rourke MD, Abstract Co-Author: Nothing to Disclose

Suyash Mohan MD, Abstract Co-Author: Nothing to Disclose

Understanding the key concepts of pseudoprogression & pseudoresponse Specific MRI features that can help differentiate between residual tumor & treatment related changes Understanding the Response Assessment in Neuro-Oncology (RANO) criteria      

Current therapy and standard of care Principles of post operative evaluation True progression vs Pseudoprogression (PsP) Treatment related/ Radiation Necrosis (RN) Antiangiogenic therapy & Pseudoresponse (PsR) Limitations of Macdonald's criteria and rationale for the RANO criteria Advanced imaging techniques in the post treatment setting - MR perfusion (DSC & DCE), DWI, MRS, and PET Future perspectives - emerging techniques in molecular imaging and radiogenomics; tumor vaccine trials

http://abstract.rsna.org/uploads/2014/14007888/14007888_twpj.pdf

Ware, J, Wolf, R, Poptani, H, O'Rourke, D, Mohan, S, Post Therapy Evaluation of Brain Tumors.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14007888.html